{"Abbreviation":"MDEA","Aliases":["MDEA","3,4-Methylenedioxy-N-ethylamphetamine","Methylenedioxyethamphetamine","N-Ethyl-mda","Eve (amphetamine)","N-Ethyl MDA","N-Ethyl-3,4-methylenedioxyamphetamine","N-MDE","MDE (+-)","ML1I4KK67B"],"CAS":"82801-81-8","ChEBI":"CHEBI:132234","ChEMBL":"CHEMBL126279","ChemicalClasses":["amphetamine","methylenedioxyphenethylamine"],"Chirality":"racemic","DEA no":7404,"DrugClasses":["antidepressant","depressant"],"European Community (EC) Number":"803-314-3","Human Drugs":"Pharmaceuticals","IUPACName":"1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine","InChI":"InChI=1S/C12H17NO2/c1-3-13-9(2)6-10-4-5-11-12(7-10)15-8-14-11/h4-5,7,9,13H,3,6,8H2,1-2H3","InChIKey":"PVXVWWANJIWJOO-UHFFFAOYSA-N","MeSH Pharmacological Classification":"Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)","MolecularFormula":"C\u003csub\u003e12\u003c/sub\u003eH\u003csub\u003e17\u003c/sub\u003eNO\u003csub\u003e2\u003c/sub\u003e","MolecularWeight":"207.27 g/mol","Opticalactivity":"( + / - )","PubChemId":105039,"Record Description":["1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine is a secondary amino compound that is N-ethylisopropylamine in which a hydrogen of one of the isopropyl methyl groups has been replaced by a 3,4-methylenedioxyphenyl group. It is a member of benzodioxoles and a secondary amino compound.","3,4-methylenedioxy-N-ethylamphetamine is a DEA Schedule I controlled substance. Substances in the DEA Schedule I have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. It is a Hallucinogenic substances substance.","1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine is a secondary amino compound that is N-ethylisopropylamine in which a hydrogen of one of the isopropyl methyl groups has been replaced by a 3,4-methylenedioxyphenyl group. It is a member of benzodioxoles and a secondary amino compound.","Wikipedia|PiHKAL|Phenethylamines"],"References":[{"name":"Wikipedia","url":"https://en.wikipedia.org/wiki/3,4-Methylenedioxy-N-ethylamphetamine"},{"name":"Wikidata","url":"https://www.wikidata.org/wiki/Q223011"},{"name":"DrugBank","url":"https://go.drugbank.com/drugs/DB01566"},{"name":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/105039"},{"name":"ChemSpider","url":"https://www.chemspider.com/Chemical-Structure.94775.html"},{"name":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL126279"},{"name":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:132234"},{"name":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=82801-81-8"},{"name":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0254369"},{"name":"KEGG","url":"https://www.kegg.jp/entry/C22717"},{"name":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/ML1I4KK67B"},{"name":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID70860971"}],"SMILES":"CCNC(C)CC1=CC2=C(C=C1)OCO2","Salts":["hydrochloride"],"StructureBase64":"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","Title":"3,4-Methylenedioxyethamphetamine","UNII":"ML1I4KK67B","Wikidata":"Q223011","XLogP":2.5}